Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro
about
Leishmania carbon metabolism in the macrophage phagolysosome- feast or famine?A new experimental model for assessing drug efficacy against Trypanosoma cruzi infection based on highly sensitive in vivo imagingGeneration of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimagingIn vivo imaging of trypanosome-brain interactions and development of a rapid screening test for drugs against CNS stage trypanosomiasisImmunoadjuvant Properties of the Rho Activating Factor CNF1 in Prophylactic and Curative Vaccination against Leishmania infantumHighly sensitive in vivo imaging of Trypanosoma brucei expressing "red-shifted" luciferaseEvaluating aziridinyl nitrobenzamide compounds as leishmanicidal prodrugsCharacterization of metabolically quiescent Leishmania parasites in murine lesions using heavy water labeling.In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type Parasite.Luminescent multiplex viability assay for Trypanosoma brucei gambiense.Experimental infection of Phlebotomus perniciosus by bioluminescent Leishmania infantum using murine model and artificial feederAutomated imaging and other developments in whole-organism anthelmintic screening.Imaging host-Leishmania interactions: significance in visceral leishmaniasis.Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?Chemotherapy of leishmaniasis: present challenges.Methods to Evaluate the Preclinical Safety and Immunogenicity of Genetically Modified Live-Attenuated Leishmania Parasite Vaccines.A real-time PCR assay for quantification of parasite burden in murine models of leishmaniasis
P2860
Q26776497-907FA73B-55A8-4101-9372-F47D4AE60764Q27011506-A1D2E6F5-73C9-4F90-984D-D1644120D78DQ27304615-D2480D9F-72C7-475C-B572-A28A41E6CC4FQ27305075-72799681-9EDC-40D7-B3EF-FE22D40D18C7Q27342880-C6D6561C-A0D2-4046-9093-9E0C4CE16344Q28535374-29D6F44F-ABF0-437A-B216-17B78E0ED018Q35027309-31E8F6B2-40D2-44ED-AEF0-B71378A8AFDDQ35122993-345AF710-54A7-4896-928E-A70CD002735AQ36050879-B46535FD-452E-4E58-8CAC-5F21EA8D5702Q37057168-D8F01C05-9A85-4FD5-B8DA-B8A05CF9DA6CQ37167717-B9174440-5335-4765-8FCB-D4AA351EF6ADQ38098597-64264B11-9A99-4BB5-896A-5ADD83EFB013Q38114928-98292B94-E4E7-4104-A032-B116B163581EQ38209866-899A7647-12B4-4824-BC58-163489AD5F93Q39011875-D578E1F7-1677-44C1-BE7C-25A13AB0F349Q51372327-654529E2-5A4F-4539-9E15-5671F353356BQ59137960-7E0319ED-49E7-4B7D-8927-558C8F10B7FE
P2860
Luciferase-expressing Leishmania infantum allows the monitoring of amastigote population size, in vivo, ex vivo and in vitro
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@ast
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@en
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@nl
type
label
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@ast
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@en
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@nl
prefLabel
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@ast
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@en
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@nl
P2093
P2860
P50
P3181
P1476
Luciferase-expressing Leishman ...... in vivo, ex vivo and in vitro
@en
P2093
Bernard Ferrua
Christelle Pomares
Grégory Michel
Madhavi P Maddugoda
Pierre Marty
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0001323
P407
P577
2011-09-01T00:00:00Z